Xeris Pharmaceuticals (XERS) just unveiled an announcement.
Xeris Biopharma Holdings, Inc. has announced the promotion of Kevin McCulloch to President and Chief Operating Officer starting August 1, 2024, with an impressive career background including senior roles at Hill-Rom and Baxter Healthcare. Alongside a $520,000 base salary, his compensation includes stock units and stock appreciation rights, with provisions for severance benefits under certain conditions. McCulloch’s extensive experience in pharmaceuticals and his education from the University of Michigan and Northwestern’s Kellogg School of Management position him as a strategic leader for the company’s future growth.
See more insights into XERS stock on TipRanks’ Stock Analysis page.
